1. Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate CancerEric…

1. Translational Drug Discovery Transforming Science into Medicine Andy Plump, MD, PhD Deputy to the President R&D, Research & Translational Medicine tranSMART Chilly-Mazarin/Longjumeau…

1. updateWinter 2014 Inside This Issue TRIAD Global Registry for Inherited Neuropathies Get Involved Team CMT Upcoming Events The Hereditary Neuropathy Foundation’s mission…

Slide 1Status Update 2009 Michael J. Fisch, MD, MPH, FACP Medical Director Slide 2 The Future is NOW Slide 3 ID00-156 (NCI 3410) A Prospective Randomized Phase III Trial…

1. Bisfosfonaten in de Oncologie Dr. H.P. Sleeboom Hagaziekenhuis Den Haag 2. Botmetastasen 3. Trabecular Bone Destroyed by Osteoclasts Due to Tumor Osteolysis Figure from…

1. GLIADEL ®WAFER sNDA 20-637s Guilford Pharmaceuticals Inc. Baltimore, Maryland 2. GLIADEL ®WaferIndication GLIADEL ®is indicated for use as an adjunct to surgery to…

disease modifying agents multiple sclerosis disease modifying agents for multiple sclerosis Presented by : DR : Hossam El Sayed Disease modifying drugs are not a cure for…

Efficacy and Safety of AM-101 in the Treatment of Acute Inner Ear TinnitusVA Double-Blind, Randomized, Placebo-Controlled Phase II Study *Paul van de Heyning, †Guido Muehlmeier,…

Slide 1 A randomized, double ‑ blind, placebo-controlled phase 2 trial of dendritic cell (DC) vaccination with ICT-107 in newly diagnosed glioblastoma (GBM) patients Presented…

State of the Art: Treatment Options in Advanced Genitourinary Cancers David I. Quinn MBBS (Hons) PhD FRACPAssociate Professor of MedicineChief, Section of GU Medical OncologyDivision…